Please assess the completion status of the following clinical trial:

Trial Title: Closed Loop Insulin Pump Therapy After Islet Auto-Transplantation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing total pancreatectomy and islet auto-transplantation.~* Patients ages 21 to 64 years old~Exclusion Criteria:~* Preexisting diabetes~* Use of acetaminophen during study period, which interferes with CGM sensor function~* Any medical condition requiring corticosteroids~* Severe Psychiatric disease or developmental delays, that might interfere with the ability to provide informed consent~* Any other medical condition which in the opinion of the investigators impairs the person's ability to safely participate in the trial

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Control (Type: NO_INTERVENTION): Control Group: patients receive conventional multiple daily injection insulin therapy with basal and bolus dosing during the 72 hour study period.
- Closed Loop Insulin (Type: EXPERIMENTAL): Closed Loop Insulin Group: patients receive continuous subcutaneous insulin controlled by experimental closed loop system during the 72 hour study period.

Based on this trial design, predict the completion outcome and termination type (if applicable).